Scinai Immunotherapeutics Ltd. vs STC Biologics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/scinai-immunotherapeutics/stcbiologics

Category	Scinai Immunotherapeutics Ltd.	STC Biologics
Listed site	both	both
Summary	Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.	Boutique biologics CDMO with a Speed-to-Clinic platform spanning royalty-free cell line development through cGMP drug substance, in as little as 12 months. Runs a single-use mammalian GMP suite in Newton, MA for antibody, bispecific, and ADC programs.
Services	CMC Analytical Development Process Development CMC Regulatory Submission Support Technology Transfer Recombinant Protein Manufacturing Biologics Development & Manufacturing	Cell-Line Development Biologics Development & Manufacturing Monoclonal Antibody (mAb) Manufacturing ADC (Antibody-Drug Conjugate) Manufacturing CMC Regulatory Submission Support
Modalities	Biologics (Monoclonal Antibodies)	Biologics (Monoclonal Antibodies) Antibody-Drug Conjugate (ADC)
Indications	Dermatology Immunology Rare Disease	Data not yet provided.
Locations	Headquarters, Jerusalem, Israel Yavne CDMO Facility, Yavne, Israel	Newton, Newton, Massachusetts, USA
Certifications	EMA · Identifier: European QP (EMA) audit passed Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.